Increased prevalence of metabolic syndrome in female patients with overactive bladder: A population‐based study
- 4 June 2024
- journal article
- research article
- Published by Wiley in Neurourology and Urodynamics
- Vol. 43 (8) , 1809-1816
Abstract
Objectives: To assess the association between overactive bladder syndrome (OAB) and the metabolic syndrome (MetS).Patients and Methods: A population‐based study was conducted to compare OAB patients with age‐, sex‐ and ethnicity‐matched control subjects regarding the prevalence of the parameters of the MetS, with respect to obesity, hyperlipidemia, hypertension and diabetes mellitus. The characteristics of the OAB population were assessed. Adjusted odds ratios (OR) were calculated by logistic regression.Results: 110 024 OAB patients and 220 455 controls. were identified. OAB was associated with a higher prevalence of MetS (35.4% vs. 27.5%, p < 0.001). The fully adjusted OR for MetS in patients with OAB compared to controls was 1.44; 95% confidence interval (CI) 1.42−1.46; p < 0.001. Among metabolic parameters, obesity was found to be the strongest factor associated with OAB (OR 1.55, 95% CI 1.53−1.58, p < 0.001), and higher high‐density lipoprotein cholesterole levels (>50) had a protective effect on the risk of OAB (OR 0.75, 95% CI 0.73−0.76, p < 0.001).Conclusions: Data from this cohort suggest that OAB is positively associated with MetS. Clinicians approaching patients with OAB should be aware of this association. A multimodal treatment focusing on the MetS may be considered in these patients.Keywords
This publication has 31 references indexed in Scilit:
- Does metabolic syndrome influence the efficacy of mirabegron treatment in female patients with overactive bladder?International Urogynecology Journal, 2022
- A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored TreatmentEuropean Urology, 2019
- Is there an association between aspects of the metabolic syndrome and overactive bladder? A prospective cohort study in women with lower urinary tract symptomsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2017
- Comparing anticholinergic persistence and adherence profiles in overactive bladder patients based on gender, obesity, and major anticholinergic agentsNeurourology and Urodynamics, 2017
- Systemic atherosclerosis and voiding symptomEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2017
- Impact of body mass index on treatment efficacy of mirabegron for overactive bladder in femalesEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2016
- Animal Models in Overactive Bladder Research2011
- The effects of chronic hyperlipidemia on bladder function in myocardial infarction‐prone Watanabe heritable hyperlipidemic (WHHLMI) rabbitsNeurourology and Urodynamics, 2010
- Effect of Weight Loss on Urinary Incontinence in Overweight and Obese Women: Results at 12 and 18 MonthsJournal of Urology, 2010
- Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC StudyEuropean Urology, 2006